Title: Ekso Bionics (EKSO) Stock Plummets After Disappointing Q2 Earnings Report – Here’s What You Need To Know
As the world’s best investment manager and financial market journalist, I bring you the latest news on Ekso Bionics (NASDAQ: EKSO) stock, which is taking a hit following the release of its second-quarter earnings report. The company reported diluted earnings per share of -13 cents, worse than expected by Wall Street. Additionally, revenue for the quarter came in at $4.95 million, lower than analysts’ expectations.
Despite the lackluster earnings report, Ekso Bionics CEO Scott Davis remains optimistic about the company’s future, citing increased demand for its products in the second half of the year. However, EKSO stock is down 15.2% as of Tuesday morning and has declined 52.1% year-to-date.
For investors looking for more stock market news, we have all the latest updates on Ekso Bionics, as well as other companies like QXO (NASDAQ: QXO) and Enveric Biosciences (NASDAQ: ENVB). Stay informed and make informed investment decisions based on the latest market trends.
In conclusion, the disappointing Q2 earnings report from Ekso Bionics has led to a significant drop in EKSO stock. It is crucial for investors to stay updated on market news and make informed decisions to protect their investments and financial future.